<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel><title>Filing Signals</title><link>https://srinivasledger.github.io/filing-signals</link><description>Weekday tracking of restatements, SEC comment letters, material weaknesses, auditor and CFO changes, and going-concern language in SEC filings.</description><lastBuildDate>Mon, 14 Sep 2026 08:28:25 +0000</lastBuildDate><item><title>Zone Frontier Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1956741/000121390026099309/0001213900-26-099309-index.htm</link><guid isPermaLink="false">caf8102146bd73af</guid><category>Finance chief departure</category><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><description>Zone Frontier Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>Transcode Therapeutics, Inc.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1829635/000110465926107115/0001104659-26-107115-index.htm</link><guid isPermaLink="false">ac92e6101d98b93a</guid><category>Finance chief departure</category><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><description>Transcode Therapeutics, Inc.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>Skye Bioscience, Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1516551/000162828026061558/0001628280-26-061558-index.htm</link><guid isPermaLink="false">d2bb7c0038bed854</guid><category>Finance chief departure</category><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><description>Skye Bioscience, Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>Peraso Inc.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/890394/000121390026099297/0001213900-26-099297-index.htm</link><guid isPermaLink="false">f0fa9cbb7e9988c1</guid><category>Finance chief departure</category><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><description>Peraso Inc.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>Korsana Biosciences, Inc.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1755237/000119312526389318/0001193125-26-389318-index.htm</link><guid isPermaLink="false">46414b577d658da3</guid><category>Finance chief departure</category><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><description>Korsana Biosciences, Inc.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>Bubblr Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1873722/000149315226042362/0001493152-26-042362-index.htm</link><guid isPermaLink="false">613fd60237b40694</guid><category>Finance chief departure</category><pubDate>Fri, 11 Sep 2026 00:00:00 +0000</pubDate><description>Bubblr Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>Versus Systems Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1701963/000121390026098586/0001213900-26-098586-index.htm</link><guid isPermaLink="false">6d8d5811470f4ad3</guid><category>Finance chief departure</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Versus Systems Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>VITASPRING BIOMEDICAL CO. LTD.'s Chief Financial Officer departed with no named successor</title><link>https://www.sec.gov/Archives/edgar/data/1697884/000164033426001485/0001640334-26-001485-index.htm</link><guid isPermaLink="false">c535fae1377f86a0</guid><category>Finance chief departure</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>VITASPRING BIOMEDICAL CO. LTD.'s Chief Financial Officer departed with no named successor</description></item><item><title>TWO HARBORS INVESTMENT CORP.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1465740/000110465926106707/0001104659-26-106707-index.htm</link><guid isPermaLink="false">76d04d3b5448e6fb</guid><category>Finance chief departure</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>TWO HARBORS INVESTMENT CORP.'s Chief Financial Officer departed and a successor was named</description></item><item><title>SCYNEXIS INC's Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1178253/000117825326000031/0001178253-26-000031-index.htm</link><guid isPermaLink="false">449134fec5719383</guid><category>Finance chief departure</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>SCYNEXIS INC's Chief Financial Officer departed and a successor was named</description></item><item><title>PRECIGEN, INC. responded to SEC staff comments on inventory</title><link>https://www.sec.gov/Archives/edgar/data/1356090/000095010326001214/0000950103-26-001214-index.htm</link><guid isPermaLink="false">e37a70a002607bae</guid><category>SEC comment letter</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Please tell us and revise to disclose, beginning with your Form 10-K for the year ended December 31, 2025, whether you track research and development (R&amp;D) expenses by candidate or program and, if not, explain why not. To the extent you track any of your R&amp;D expenses by candidate or program, provide a breakout of such amounts. For the R&amp;D expenses you do not track by candidate or program, revise to provide a…</description></item><item><title>PRECIGEN, INC. responded to SEC staff comments on segment reporting</title><link>https://www.sec.gov/Archives/edgar/data/1356090/000095010326002499/0000950103-26-002499-index.htm</link><guid isPermaLink="false">28cd7fc115ac7333</guid><category>SEC comment letter</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Please tell us what financial information is received by the CODM, and how it changed in the first quarter of 2025 and subsequent periods. · Clarify how the financial information for these reporting units is used, and how the uses of this information changed beginning in the first quarter of 2025 and subsequent periods. · Specifically identify what, if any, information is received but not regularly used, related to…</description></item><item><title>SEC staff questioned PRECIGEN, INC.'s accounting for inventory</title><link>https://www.sec.gov/Archives/edgar/data/1356090/000000000025011799/0000000000-25-011799-index.htm</link><guid isPermaLink="false">624712c2bc56eece</guid><category>SEC comment letter</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Please tell us and revise to disclose, beginning with your Form 10-K for the year ended December 31, 2025, whether you track research and development (R&amp;D) expenses by candidate or program and, if not, explain why not. To the extent you track any of your R&amp;D expenses by candidate or program, provide a breakout of such amounts. For the R&amp;D expenses you do not track by candidate or program, revise to provide a…</description></item><item><title>SEC staff questioned PRECIGEN, INC.'s accounting for segment reporting</title><link>https://www.sec.gov/Archives/edgar/data/1356090/000000000026001372/0000000000-26-001372-index.htm</link><guid isPermaLink="false">6d3f37d48f3bf36c</guid><category>SEC comment letter</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Please tell us what financial information is received by the CODM, and how it changed in the first quarter of 2025 and subsequent periods. Clarify how the financial information for these reporting units is used, and how the • 1. uses of this information changed beginning in the first quarter of 2025 and subsequent periods. • Specifically identify what, if any, information is received but not regularly used, related…</description></item><item><title>Lionsgate Studios Corp. responded to SEC staff comments on non-GAAP measures</title><link>https://www.sec.gov/Archives/edgar/data/2052959/000205295926000059/0002052959-26-000059-index.htm</link><guid isPermaLink="false">fa11de4adbb5e6fa</guid><category>SEC comment letter</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>We note your disclosure of gross contribution and gross contribution as a percentage of revenue for each of your segments. Please explain how you determined that these were not non-GAAP measures which would require a reconciliation to the most comparable GAAP measure. In this regard, we note that you disclose segment profit as your primary measure of segment performance. As gross contribution would appear to be an…</description></item><item><title>SEC staff questioned Lionsgate Studios Corp.'s accounting for non-GAAP measures</title><link>https://www.sec.gov/Archives/edgar/data/2052959/000000000026007220/0000000000-26-007220-index.htm</link><guid isPermaLink="false">44bc4ef2c3e1e33a</guid><category>SEC comment letter</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>We note your disclosure of gross contribution and gross contribution as a percentage of revenue for each of your segments. Please explain how you determined that these were not non-GAAP measures which would require a reconciliation to the most comparable GAAP measure. In this regard, we note that you disclose segment profit as your primary measure of segment performance. As gross contribution would appear to be an…</description></item><item><title>Fortrea Holdings Inc.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1965040/000162828026061218/0001628280-26-061218-index.htm</link><guid isPermaLink="false">2bebd3451e27ad2d</guid><category>Finance chief departure</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Fortrea Holdings Inc.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>COMPUGEN LTD responded to SEC staff comments on revenue recognition</title><link>https://www.sec.gov/Archives/edgar/data/1119774/000117891326003609/0001178913-26-003609-index.htm</link><guid isPermaLink="false">8246589d72c3c9d8</guid><category>SEC comment letter</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Please revise your future filings to quantify the amount of the transaction price allocated to each unsatisfied (or partially satisfied) performance obligation as of the end of each reporting period and an explanation as to the period over which you expect to recognize the remaining revenue. In this regard, we note that $35.9 million remains unrecognized as deferred revenue, and that you expect to recognize 31% of…</description></item><item><title>SEC staff questioned COMPUGEN LTD's accounting for revenue recognition</title><link>https://www.sec.gov/Archives/edgar/data/1119774/000000000026007171/0000000000-26-007171-index.htm</link><guid isPermaLink="false">bc7d8b4ad14cea68</guid><category>SEC comment letter</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Please revise your 2. future filings to quantify the amount of the transaction price allocated to each unsatisfied (or partially satisfied) performance obligation as of the end of each reporting period and an explanation as to the period over which you expect to recognize the remaining revenue. In this regard, we note that $35.9 million remains unrecognized as deferred revenue, and that you expect to recognize 31%…</description></item><item><title>BioRestorative Therapies, Inc. moved from CBIZ to Bush &amp; Associates CPA</title><link>https://www.sec.gov/Archives/edgar/data/1505497/000121390026098820/0001213900-26-098820-index.htm</link><guid isPermaLink="false">9b18116c4e549977</guid><category>Auditor change</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>BioRestorative Therapies, Inc. moved from CBIZ to Bush &amp; Associates CPA</description></item><item><title>Ameresco, Inc.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1488139/000162828026061392/0001628280-26-061392-index.htm</link><guid isPermaLink="false">ecf3ff42df54d47b</guid><category>Finance chief departure</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>Ameresco, Inc.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>AZIO AI HOLDINGS, INC. dismissed Barton CPA, PLLC and engaged TAAD LLP</title><link>https://www.sec.gov/Archives/edgar/data/1563568/000143774926030077/0001437749-26-030077-index.htm</link><guid isPermaLink="false">557e7e366fe86bba</guid><category>Auditor change</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>AZIO AI HOLDINGS, INC. dismissed Barton CPA, PLLC and engaged TAAD LLP</description></item><item><title>AURA SYSTEMS INC reported a material weakness in internal control</title><link>https://www.sec.gov/Archives/edgar/data/826253/000121390026098484/0001213900-26-098484-index.htm</link><guid isPermaLink="false">c0db55f18ed9f6e6</guid><category>Material weakness</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>GAAP knowledge and experience and ongoing training in the application of U.S. GAAP and SEC disclosure requirements commensurate with the Company’s financial reporting requirements. Notwithstanding the identified material weaknesses, management has concluded that the Financial Statements included in this Annual Report on Form 10-K present fairly, in all material respects, the Company’s financial position, results of operations and cash flows for the periods disclosed in conformity with U.S. GAAP. 24 Planned…</description></item><item><title>APTARGROUP, INC.'s Chief Accounting Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/896622/000110465926106706/0001104659-26-106706-index.htm</link><guid isPermaLink="false">028015b0dfa7f124</guid><category>Finance chief departure</category><pubDate>Thu, 10 Sep 2026 00:00:00 +0000</pubDate><description>APTARGROUP, INC.'s Chief Accounting Officer departed, replaced on an interim basis</description></item><item><title>WW INTERNATIONAL, INC.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/105319/000119312526385911/0001193125-26-385911-index.htm</link><guid isPermaLink="false">66d249823a7fdee3</guid><category>Finance chief departure</category><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><description>WW INTERNATIONAL, INC.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>SDR Drone, Inc. said previously issued financial statements should no longer be relied upon</title><link>https://www.sec.gov/Archives/edgar/data/1331421/000149315226041986/0001493152-26-041986-index.htm</link><guid isPermaLink="false">0a072165dc4a4158</guid><category>Restatement</category><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><description>SDR Drone, Inc. said previously issued financial statements should no longer be relied upon</description></item><item><title>Lyft, Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1759509/000162828026061020/0001628280-26-061020-index.htm</link><guid isPermaLink="false">8824b8a0dcf3d331</guid><category>Finance chief departure</category><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><description>Lyft, Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>LEE ENTERPRISES, Inc reported a change in its independent accounting firm</title><link>https://www.sec.gov/Archives/edgar/data/58361/000005836126000067/0000058361-26-000067-index.htm</link><guid isPermaLink="false">c927efbb0c117dc6</guid><category>Auditor change</category><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><description>LEE ENTERPRISES, Inc reported a change in its independent accounting firm</description></item><item><title>InnovAge Holding Corp. changed its revenue recognition disclosure</title><link>https://www.sec.gov/Archives/edgar/data/1834376/000183437626000049/0001834376-26-000049-index.htm</link><guid isPermaLink="false">4067ca6ccbc23355</guid><category>Revenue recognition change</category><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><description>The Company recognizes revenue in accordance with Accounting Standards Codification Topic 606, Revenue from Contracts with Customers (“ASC 606”).</description></item><item><title>InMed Pharmaceuticals Inc. disclosed substantial doubt about its ability to continue as a going concern</title><link>https://www.sec.gov/Archives/edgar/data/1728328/000121390026098419/0001213900-26-098419-index.htm</link><guid isPermaLink="false">60847704296c40a2</guid><category>Going concern</category><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><description>Explanatory Paragraph – Going Concern The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. As more fully described in Note 1, the Company has a significant working capital deficiency, has incurred significant losses and needs to raise additional funds to meet its obligations and sustain its operations. These conditions raise substantial doubt about the Company's ability to continue as a going concern. Management's plans in regard to these matters are also described in Note 1. The consolidated financial statements do…</description></item><item><title>Cornerstone Building Brands, Inc.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/883902/000110465926106157/0001104659-26-106157-index.htm</link><guid isPermaLink="false">fdf867b6ec1463b6</guid><category>Finance chief departure</category><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><description>Cornerstone Building Brands, Inc.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>AMERICAS CARMART INC disclosed substantial doubt about its ability to continue as a going concern</title><link>https://www.sec.gov/Archives/edgar/data/799850/000162828026061105/0001628280-26-061105-index.htm</link><guid isPermaLink="false">e2493440e1dbc269</guid><category>Going concern</category><pubDate>Wed, 09 Sep 2026 00:00:00 +0000</pubDate><description>B – Liquidity and Going Concern In accordance with Accounting Standards Codification (“ASC”) 205-40, Presentation of Financial Statements – Going Concern, management has the responsibility to evaluate whether conditions and/or events raise substantial doubt about the Company’s ability to meet its future financial obligations as they become due within one year after the date that the Condensed Consolidated Financial Statements are issued. This evaluation requires management to perform two steps. First, management must evaluate whether there are conditions and events that raise substantial…</description></item><item><title>Nerdy Inc.'s Chief Accounting Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1819404/000181940426000097/0001819404-26-000097-index.htm</link><guid isPermaLink="false">85b2cb9c32c5151d</guid><category>Finance chief departure</category><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><description>Nerdy Inc.'s Chief Accounting Officer departed and a successor was named</description></item><item><title>MSC INDUSTRIAL DIRECT CO INC's Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1003078/000100307826000094/0001003078-26-000094-index.htm</link><guid isPermaLink="false">150a5110ee9bb323</guid><category>Finance chief departure</category><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><description>MSC INDUSTRIAL DIRECT CO INC's Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>Genpact LTD's Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1398659/000110465926105722/0001104659-26-105722-index.htm</link><guid isPermaLink="false">c5f437a4406b00b0</guid><category>Finance chief departure</category><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><description>Genpact LTD's Chief Financial Officer departed and a successor was named</description></item><item><title>Exascale Labs Holdings Inc.'s Chief Financial Officer departed, with the filing citing misconduct</title><link>https://www.sec.gov/Archives/edgar/data/2109869/000182912626009860/0001829126-26-009860-index.htm</link><guid isPermaLink="false">c382c8cb497dda79</guid><category>Finance chief departure</category><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><description>Exascale Labs Holdings Inc.'s Chief Financial Officer departed, with the filing citing misconduct</description></item><item><title>Crescent Private Credit Income Corp responded to SEC staff comments on MD&amp;A</title><link>https://www.sec.gov/Archives/edgar/data/1954360/000119312526068733/0001193125-26-068733-index.htm</link><guid isPermaLink="false">84e777e04d9b97d3</guid><category>SEC comment letter</category><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><description>We note that “Other general and administrative expenses” appear to be significant. Please confirm that any categories of other expenses that exceed 5% of total expenses have been separately identified in accordance with Regulation S-X 6-07.2(b). Response: The Fund advises the Staff that for the fiscal year ended December 31, 2024, the $2,258 thousand of “Other general and administrative expenses” set forth on the…</description></item><item><title>Aterian, Inc.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1757715/000143774926029837/0001437749-26-029837-index.htm</link><guid isPermaLink="false">589c1490e0b31764</guid><category>Finance chief departure</category><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><description>Aterian, Inc.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>AdaptHealth Corp.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1725255/000110465926105912/0001104659-26-105912-index.htm</link><guid isPermaLink="false">0666d3a62f44ecfc</guid><category>Finance chief departure</category><pubDate>Tue, 08 Sep 2026 00:00:00 +0000</pubDate><description>AdaptHealth Corp.'s Chief Financial Officer departed and a successor was named</description></item><item><title>Weatherford International plc's Chief Accounting Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1603923/000160392326000108/0001603923-26-000108-index.htm</link><guid isPermaLink="false">ca38ae962c1d08e7</guid><category>Finance chief departure</category><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><description>Weatherford International plc's Chief Accounting Officer departed and a successor was named</description></item><item><title>VISTA CREDIT STRATEGIC LENDING CORP. responded to SEC staff comments on revenue recognition</title><link>https://www.sec.gov/Archives/edgar/data/1919369/000119312526326319/0001193125-26-326319-index.htm</link><guid isPermaLink="false">f97712fe1d7facf7</guid><category>SEC comment letter</category><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><description>Please explain why these amounts are recorded to the balance sheet if these amounts are subject to the standard recoupment terms. Response: The Fund advises the Staff that the “Expense Support Reimbursement” and “Due to Adviser” balances arise from different aspects of the ESA Agreement and are not duplicative. The “Expense Support Reimbursement” balance represents the cumulative Expense Payments made by the Adviser…</description></item><item><title>REGENEREX PHARMA, INC.'s auditor resigned</title><link>https://www.sec.gov/Archives/edgar/data/1357878/000147237526000217/0001472375-26-000217-index.htm</link><guid isPermaLink="false">57559ba19564d5df</guid><category>Auditor change</category><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><description>REGENEREX PHARMA, INC.'s auditor resigned</description></item><item><title>RAMBUS INC's Chief Accounting Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/917273/000119312526383630/0001193125-26-383630-index.htm</link><guid isPermaLink="false">6e5913a72cf3e5e0</guid><category>Finance chief departure</category><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><description>RAMBUS INC's Chief Accounting Officer departed and a successor was named</description></item><item><title>Katapult Holdings, Inc. moved from Grant Thornton to Elliott Davis, PLLC</title><link>https://www.sec.gov/Archives/edgar/data/1785424/000110465926105493/0001104659-26-105493-index.htm</link><guid isPermaLink="false">3291084fbcb960a9</guid><category>Auditor change</category><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><description>Katapult Holdings, Inc. moved from Grant Thornton to Elliott Davis, PLLC</description></item><item><title>Fusemachines Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/2033383/000149315226041553/0001493152-26-041553-index.htm</link><guid isPermaLink="false">48fff81fbacbe962</guid><category>Finance chief departure</category><pubDate>Fri, 04 Sep 2026 00:00:00 +0000</pubDate><description>Fusemachines Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>T-Mobile US, Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1283699/000119312526381901/0001193125-26-381901-index.htm</link><guid isPermaLink="false">f02ef9c99e6f4d4a</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>T-Mobile US, Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>RESOURCES CONNECTION, INC.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1084765/000108476526000059/0001084765-26-000059-index.htm</link><guid isPermaLink="false">796a7635c59d52d7</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>RESOURCES CONNECTION, INC.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>NETSTREIT Corp.'s Chief Accounting Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1798100/000162828026060402/0001628280-26-060402-index.htm</link><guid isPermaLink="false">3e284b3654ed7261</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>NETSTREIT Corp.'s Chief Accounting Officer departed and a successor was named</description></item><item><title>MediaAlpha, Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1818383/000181838326000229/0001818383-26-000229-index.htm</link><guid isPermaLink="false">64eb5f1f457db809</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>MediaAlpha, Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>Guidewire Software, Inc.'s Chief Accounting Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1528396/000152839626000039/0001528396-26-000039-index.htm</link><guid isPermaLink="false">824c83af7d15247a</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>Guidewire Software, Inc.'s Chief Accounting Officer departed and a successor was named</description></item><item><title>GrabAGun Digital Holdings Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/2051380/000119312526382024/0001193125-26-382024-index.htm</link><guid isPermaLink="false">f5e419553bf851eb</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>GrabAGun Digital Holdings Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>DOMO, INC. disclosed substantial doubt about its ability to continue as a going concern</title><link>https://www.sec.gov/Archives/edgar/data/1505952/000162828026060537/0001628280-26-060537-index.htm</link><guid isPermaLink="false">cd5fe7e3b0f9a186</guid><category>Going concern</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>The Company had cash and cash equivalents of $25.1 million as of July 31, 2026, which would not be sufficient to repay the term loan upon any such 9 Domo, Inc. Notes to Condensed Consolidated Financial Statements (Continued) (unaudited) 1. Overview and Basis of Presentation (Continued) acceleration. As such, substantial doubt exists about the Company's ability to continue as a going concern within one year after the date these condensed consolidated financial statements are issued. In connection with the covenant noncompliance described above, the Company entered into a forbearance agreement…</description></item><item><title>CarGurus, Inc.'s Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1494259/000119312526381142/0001193125-26-381142-index.htm</link><guid isPermaLink="false">a345771b9dc7a8f2</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>CarGurus, Inc.'s Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>Bunge Global SA's Chief Accounting Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1996862/000162828026060388/0001628280-26-060388-index.htm</link><guid isPermaLink="false">85c541ae77bb182e</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>Bunge Global SA's Chief Accounting Officer departed and a successor was named</description></item><item><title>Bally's Corp's Chief Financial Officer departed, replaced on an interim basis</title><link>https://www.sec.gov/Archives/edgar/data/1747079/000174707926000086/0001747079-26-000086-index.htm</link><guid isPermaLink="false">a9fc4be799c7513d</guid><category>Finance chief departure</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>Bally's Corp's Chief Financial Officer departed, replaced on an interim basis</description></item><item><title>BCB BANCORP INC dismissed its auditor and engaged Deloitte</title><link>https://www.sec.gov/Archives/edgar/data/1228454/000119312526381867/0001193125-26-381867-index.htm</link><guid isPermaLink="false">f450243e931fd434</guid><category>Auditor change</category><pubDate>Thu, 03 Sep 2026 00:00:00 +0000</pubDate><description>BCB BANCORP INC dismissed its auditor and engaged Deloitte</description></item><item><title>TScan Therapeutics, Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/1783328/000119312526379343/0001193125-26-379343-index.htm</link><guid isPermaLink="false">e558eb957f17ee2f</guid><category>Finance chief departure</category><pubDate>Wed, 02 Sep 2026 00:00:00 +0000</pubDate><description>TScan Therapeutics, Inc.'s Chief Financial Officer departed and a successor was named</description></item><item><title>SMITH &amp; WESSON BRANDS, INC. responded to SEC staff comments on leases</title><link>https://www.sec.gov/Archives/edgar/data/1092796/000119312526031459/0001193125-26-031459-index.htm</link><guid isPermaLink="false">86025900ef9b9262</guid><category>SEC comment letter</category><pubDate>Wed, 02 Sep 2026 00:00:00 +0000</pubDate><description>We note your disclosure that as part of the Relocation, on January 31, 2023, you entered into (i) an assignment and assumption agreement with AOUT, pursuant to which AOUT assumed all of your rights, entitlement, and obligations in, to, and under the Missouri Lease, or the Assignment and Assumption Agreement, and (ii) an amended and restated guaranty in favor of RCS-S&amp;W Facility, LLC, as successor in interest to the…</description></item><item><title>SEC staff questioned SMITH &amp; WESSON BRANDS, INC.'s accounting for leases</title><link>https://www.sec.gov/Archives/edgar/data/1092796/000000000026000604/0000000000-26-000604-index.htm</link><guid isPermaLink="false">25fa479964d2d011</guid><category>SEC comment letter</category><pubDate>Wed, 02 Sep 2026 00:00:00 +0000</pubDate><description>We note your disclosure that as part of the Relocation, on January 31, 2023, you entered into (i) an assignment and assumption agreement with AOUT, pursuant to which AOUT assumed all of your rights, entitlement, and obligations in, to, and under the Missouri Lease, or the Assignment and Assumption Agreement, and (ii) an amended and restated guaranty in favor of RCS-S&amp;W Facility, LLC, as successor in interest to the…</description></item><item><title>NPK International Inc.'s Chief Financial Officer departed and a successor was named</title><link>https://www.sec.gov/Archives/edgar/data/71829/000007182926000047/0000071829-26-000047-index.htm</link><guid isPermaLink="false">580d0c4ea372ba6c</guid><category>Finance chief departure</category><pubDate>Wed, 02 Sep 2026 00:00:00 +0000</pubDate><description>NPK International Inc.'s Chief Financial Officer departed and a successor was named</description></item></channel></rss>
